Schizophrenia Research Forum: Annotation

For Patients & Families


	Recent Updates

	Current Papers

	Search All Papers

	Search Comments

	Research News

	Conference News

	Current Hypotheses

	Idea Lab

	Online Discussions

	Virtual Conferences

	Interviews


	What We Know

	SchizophreniaGene

	Animal Models

	Drugs in Trials

	Research Tools

	Grants

	Jobs

	Conferences

	Journals

	Community Calendar

	General Information

	Member Directory

	Researcher Profiles

	Institutes and Labs

	Mission

	History

	SRF Team

	Advisory Board

	Support Us

	How to Cite

	Fan (E)Mail



	The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.

	Annotation


	Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther . 2007 Jan ; 320(1):365-75. PubMed Abstract

Submit a Comment on this Paper

Make a comment on this paper.

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name
*Last Name
Affiliation
Country or Territory
*Login Email Address
*Confirm Email Address
*Password
*Confirm Password
Remember my Login and Password?
Get SRF newsletter with recent commentary?

Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend this paper

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:





			SRF News SRF Comments Text Size Reset Text Size Email this page